PROFESSIONAL EDITION

The largest community of pharma leaders

Industry News

      Endeavor BioMedicines Doses First Patient in Phase 2 Clinical Trial of Taladegib (ENV-101) for Idiopathic Pulmonary Fibrosis; Appoints Chief Medical Officer

      SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines, a clinical-stage precision medicine company targeting the core drivers of multiple terminal diseases including oncology and fibrosis, announced that the...

      Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19

      FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy...

      Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development

      TORONTO & SHANGHAI--(BUSINESS WIRE)--Cyclica, the partner of choice for data-driven drug discovery, and IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development...

      Poxel Completes Enrollment in Phase 2 NASH Trial for PXL065 (DESTINY-1) in Biopsy-Proven Patients

      LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext – POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic diseases with metabolic pathophysiology, including...

      Clinical Investigation Shows Herb-Pharma’s ViroStop Spray Effective in Reducing Impact of Covid-19

      ZURICH--(BUSINESS WIRE)--A recent clinical study has shown that the ViroStop anti-viral spray from Swiss company, Herb-Pharma is effective in reducing the impact of Covid-19...

      Recent Articles